MARKET

RNA

RNA

Atrium Therapeutics, Inc
NASDAQ
8.29
+0.10
+1.22%
After Hours: 8.12 -0.17 -2.05% 19:30 09/25 EDT
OPEN
8.20
PREV CLOSE
8.19
HIGH
8.37
LOW
8.10
VOLUME
221.43K
TURNOVER
--
52 WEEK HIGH
16.77
52 WEEK LOW
8.10
MARKET CAP
141.81M
P/E (TTM)
-2.1505
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RNA last week (0914-0918)?
Weekly Report · 6d ago
Weekly Report: what happened at RNA last week (0907-0911)?
Weekly Report · 09/14 10:37
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 09/08 17:06
Weekly Report: what happened at RNA last week (0831-0904)?
Weekly Report · 09/07 10:29
Weekly Report: what happened at RNA last week (0824-0828)?
Weekly Report · 08/31 10:37
Weekly Report: what happened at RNA last week (0817-0821)?
Weekly Report · 08/24 10:38
Analysts Are Bullish on Top NA Stocks: Atrium Therapeutics, Inc. (RNA), BitGo Holdings, Inc. Class A (BTGO)
TipRanks · 08/17 11:30
Weekly Report: what happened at RNA last week (0810-0814)?
Weekly Report · 08/17 10:39
More
About RNA
Atrium Therapeutics, Inc. is a biopharmaceutical company engaged in the delivery of ribonucleic acid (RNA) therapeutics for people living with cardiomyopathy. Its technology leverages the targeted RNA delivery platform, which combines the tissue selectivity of monoclonal antibodies (mAbs) and other targeted delivery ligands with oligonucleotides. It is designed to allow selective targeting of the underlying genetic drivers of disease. Its development pipeline consists of programs that target genetically validated drivers of cardiomyopathy, which include Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) and Phospholamban (PLN). Its genetic drivers are associated with PRKAG2 syndrome and PLN cardiomyopathy, which is a genetic heart condition associated with life-threatening forms of heart disease. Its programs are supported by preclinical data, in addition to positive clinical data generated in neuromuscular indications using the same RNA delivery platform technology.

Webull offers Atrium Therapeutics Inc stock information, including NASDAQ: RNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNA stock methods without spending real money on the virtual paper trading platform.